[1] Miyazaki Y, Shibuya M, Sugawara H, et al. Salinomycin, a new polyether antibiotic [J].J Antibiot(Tokyo), 1974, 27(11):814-821.

[2] Huczynski A.Salinomycin:a new cancer drug candidate[J].Chem Biol Drug Des, 2012, 79(3):235-238.

[3] Mitani M, Yamanishi T, Miyazaki Y, et al.Salinomycin effects on mitochondrial ion translocation and respiration[J].Antimicrob Agents Chemother, 1976, 9(4):655-660.

[4] Gupta PB, Onder TT, Jiang G, et al.Identification of selective inhibitors of cancer stem cells by high-throughput screening[J].Cell, 2009, 138(4):645-659.

[5] Björklund P, Svedlund J, Olsson AK, et al.The internally truncated LRP5 receptor presents a therapeutic target in breast cancer[J].PLoS One, 2009, 4:e4243.

[6] Liu CC, Prior J, Piwnica-Worms D, et al.LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy[J].Proc Natl Acad Sci USA, 2010, 107:5136-5141.

[7] Zhang Y, Zhang H, Wang X, et al.The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles[J].Biomaterials, 2012, 33(2):679-691.

[8] King TD, Suto MJ, Li Y.The wnt/β-catenin signaling pathway:A potential therapeutic target in the treatment of triple negative breast cancer[J].J Cell Biochem, 2012, 113(1):13-18.

[9] Zhi QM, Chen XH, Ji J, et al.Salinomycin can effectively kill ALDH(high)stem-like cells on gastric cancer[J].Biomed Pharmacother, 2011, 65(7):509-515.

[10] Mao J, Fan S, Ma W, et al.Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment[J].Cell Death Dis, 2014, 5(1):e1039.

[11] Dong TT, Zhou HM, Wang LL.Salinomycin selectively targets 'CD133⁺' cell subpopulations and decreases malignant traits in colorectal cancerlines[J].Ann Surg Oncol, 2011, 18(6):1797-804.

[12] Kim KY, Yu SN, Lee SY, et al.Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization[J].Biochem Biophys Res Commun, 2011, 413(1):80-86.

[13] Ketola K, Hilvo M, Hyötyläinen T, et al.Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress[J].Br J Cancer, 2012, 106(1):99-106.

[14] He L, Wang F, Dai W Q, et al.Mechanism of action of salinomycin on growth and migration in pancreatic cancer cell lines[J].Pancreatology, 2012, 13(1):72-78.

[15] Zhang GN, Liang Y, Zhou LJ, et al.Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells[J].Cancer Lett, 2011, 313(2):137-144.

[16] Wang F, He L, Dai WQ, et al.Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo[J].PLoS One, 2012, 7(12):e50638.

[17] Lee S, Schmitt CA.Chemotherapy response and resistance[J].Curr Opin Genet Dev, 2003, 13(1):90-96.

[18] Leibowitz B, Yu J.Mitochondrial signaling in cell death via the Bcl-2 family[J].Cancer Biol Ther, 2010, 9(6):417-422.

[19] Liang J.Transmembrane protein 198 promotes LRP6 phosphoryla-tion and Wnt signaling activation[J].Mol Cell Biol, 2011, 31:2577-2590

[20] Hsu HC, Jeng YM, Mao TL, et al.β-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis[J].Am J Pathol, 2000, 157(3):763-770.

[21] Hou Y, Zou Q, Ge R, et al.The critical role of CD133⁺ CD44⁺/high tumor cells in hematogenous metastasis of liver cancers[J].Cell Res, 2011, 22(1):259-272.

[22] Ma S, Chan KW, Hu L, et al.Identification and characterization of tumorigenic liver cancer stem/progenitor cells[J].Gastroenterology, 2007, 132(7):2542-2556.

[23] Piao LS, Hur W, Kim TK, et al.CD133⁺liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma[J].Cancer Lett, 2012, 315(2):129-137.

[24] Parajuli B, Lee HG, Kwon SH, et al.Salinomycin inhibits Akt/NF-κB and induces apoptosis in cisplatin resistant ovarian cancer cells[J].Cancer Epidemiol, 2013, 37(4):512-517.

[25] Zhang B, Wang X, Cai F, et al.Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK[J].Tumor Biol, 2012, 33(6):1855-1862.

[26] Arafat K, Iratni R, Takahashi T, et al.Inhibitory effects of salinomycin on cell survival, colony growth, migration, and invasion of human non-Small cell lung cancer A549 and LNM35:involvement of NAG-1[J].PLoS One, 2013, 8(6):e66931.

[27] Wang Y.Effects of salinomycin on cancer stem cell in human lung adenocarcinoma A549 cells[J].Med Chem, 2011, 7(2):106-111.

[28] 曾葭, 刘成, 祝爱珍, 等.盐霉素抑制人肺癌耐顺铂细胞株A549/DDP增殖及诱导凋亡的机制[J].中国病理生理学杂志, 2012, 28(5):834-838.

[29] 欧仁杰, 石爱平, 杨红梅, 等.盐霉素对人膀胱癌5637细胞的生长抑制作用[J].吉林大学学报:医学版, 2014, 40(3):607-611.

[30] Lu D, Choi MY, Yu J, et al.Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells[J].Proc Nat Acad Sci, 2011, 108(32):13253-13257.

[31] Fuchs D, Heinold A, Opelz G, et al.Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells[J].Biochem Biophys Res Commun, 2009, 390(3):743-749.

[32] Riccioni R, Dupuis ML, Bernabei M, et al.The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor[J].Blood Cells Mol Dis, 2010, 45(1):86-92.

[33] Tang QL, Zhao ZQ, Li J, et al.Salinomycin inhibits osteosarcoma by targeting its tumor stem cells[J].Cancer Lett, 2011, 311(1):113-121.

[34] Li Y, Fang J, Wu S, et al.Identification and quantification of salinomycin in intoxicated human plasma by liquid chromatography-electrospray tandem mass spectrometry[J].Anal Bioanal Chem, 2010, 398(2):955-961.

[35] 张锡刚, 王浩春, 刘鹏, 等.聚醚酯类抗生素盐霉素中毒的诊治[J].中国急救复苏与灾害医学杂志, 2009, 1:10-12.